Showing results (2151-2160 of 2,466) with videos related to
Sort By:
Pageof 247
Therapie|January 1, 1991
[Diffusion of minocycline in pulmonary tissue]E Naline, J P Roudière, P Cordonnier, et al.Therapie|January 24, 2025
BRAF and MEK inhibitors rechallenge after an adverse drug reaction in patients with cancer: A pharmacovigilance cohort studyEmilien Ezine, Angélique Da Silva, Safa Idoudi, et al.Therapie|January 15, 2025
Health data: Regionalised access is a priority challenge for building a secure, transparent and innovative national health data repositoryDaniel Szeftel, Vianney Jouhet, Gilles Duluc, et al.Therapie|March 27, 2025
Clinical consequences of varenicline shortage: A study on the French national pharmacovigilance databaseAmélie Lepert, Delphine Bourneau-Martin, Bénédicte Lebrun-Vignes, et al.Therapie|December 22, 2024
How can the reform of the activity-based payment system (T2A) help in financing innovative health products?Xavier Armoiry, Nejma Saidani, Martine Aoustin, et al.Therapie|December 18, 2024
The French Addictovigilance Network - A multidisciplinary successful journey in the protection of public healthAna Carmona AraújoTherapie|December 4, 2024
Non-medical nitrous oxide misuse: From identifying a signal to unprecedented addictovigilance network communicationMarylène Guerlais, Sylvie Deheul, , et al.Therapie|December 22, 2024
Monitoring opioid analgesic misuse, abuse and dependence: What to the data from addictovigilance tell us about the situation in France?Maryse Lapeyre-Mestre, Celian Bertin, Constança Jalles, et al.Therapie|December 17, 2024
[ISO 9001 certification: Experience of the immunology and cell therapy laboratory at Ibn Sina University Hospital, Rabat]Nada Saout, Ouafa Atouf, Malika EssakalliTherapie|November 12, 2024
DRAMES and DTA databases: Complementary tools to monitor drug-related deaths in FranceBruno Revol, Théo Willeman, Marc Manceau, et al.Pageof 247